Takeda Pharmaceutical Company
Global headquarters in Nihonbashi | |
Native name | 武田薬品工業株式会社 |
|---|---|
Romanized name | Takeda Yakuhin Kōgyō kabushiki gaisha |
| Formerly | Chobei Takeda & Co., Ltd. (1925–1943) Takeda Pharmaceutical Industries, Ltd. (English name only 1943–1961) Takeda Chemical Industries, Ltd. (English name only 1961–2004) |
| Company type | Public KK |
| Industry | Pharmaceuticals |
| Founded | Doshomachi, Osaka, Japan (12 June 1781) |
| Founder | Chobei Takeda I |
| Headquarters | , Japan |
Key people | Yasuchika Hasegawa (Chairman of the Board) Christophe Weber (President & CEO) |
| Revenue | ¥4.03 trillion (FY 2022) |
| ¥490.51 billion (FY 2022) | |
| ¥317.02 billion (FY 2022) | |
| Total assets | ¥13.96 trillion (FY 2022) |
| Total equity | ¥6.35 trillion (FY 2022) |
| Owners |
|
Number of employees |
|
| Website | www |
| Footnotes / references | |
The Takeda Pharmaceutical Company Limited (武田薬品工業株式会社, Takeda Yakuhin Kōgyō kabushiki gaisha) [takeꜜda jakɯçiŋ koꜜːɡʲoː] is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following its merger with Shire). The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda.